Cara Therapeutics Inc (NASDAQ:CARA)
| 12.45 Delayed Data As of 3:59pm ET |  +0.13 / +1.06%Today’s Change | 7.40 Today|||52-Week Range 13.97 | +2.22% Year-to-Date |
Latest CARA News | Press Releases
No recent news for Cara Therapeutics Inc.
Today’s Trading
| Previous close | 12.32 |
| Today’s open | 12.27 |
| Day’s range | 12.27 - 12.47 |
| Volume | 7,037 |
| Average volume (3 months) | 368,488 |
| Market cap | $686.2M |
Data as of 3:59pm ET, 12/07/2022
Growth & Valuation
| Earnings growth (last year) | -1,082.98% |
| Earnings growth (this year) | +23.99% |
| Earnings growth (next 5 years) | -66.83% |
| Revenue growth (last year) | -82.95% |
| P/E ratio | NM |
| Price/Sales | 26.83 |
| Price/Book | 3.00 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| EDITEditas Medicine Inc | +0.29 | +3.06% |
| MRSNMersana Therapeutics... | -0.36 | -5.10% |
| ANIPANI Pharmaceuticals ... | +0.41 | +1.10% |
| BLUEbluebird bio Inc | +0.10 | +1.28% |
Data as of 4:00pm ET, 12/07/2022
Financials
| Next reporting date | March 15, 2023 |
| EPS forecast (this quarter) | -$0.31 |
| Annual revenue (last year) | $23.0M |
| Annual profit (last year) | -$88.4M |
| Net profit margin | -384.06% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Stamford, Connecticut |
Forecasts
